Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic ...

But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. The best way to find great value stocks is to pair a strong Zacks Rank with an ...

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...

Is now the time to buy Vertex Pharmaceuticals, or should you be careful about including it in your portfolio? Check out our in-depth research report to see what our analysts have to say, it’s free. We ...

Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...

Pivoting to Greater Boston’s next growth sectors has sustained Columbia Construction during a century of activity in the ...

Aashima Gupta leads health tech projects for the massive cloud computing company. Here, she shares why she’s excited about ...

Detailed price information for Arista Networks Inc (ANET-N) from The Globe and Mail including charting and trades.

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

Tariff worries pushed the ASX down, coal took a hit after Macquarie's call, while gold climbed as the market edged closer to ...

For years, corporate boardrooms and executive suites have been dominated by men, but for Ms Mosha, breaking barriers in human ...